Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/30/2025

Histoplasma Antibody Testing Guidelines

Diagnostic Performance

  • The American Thoracic Society recommends that sensitivity ranges from 80-95% for pulmonary histoplasmosis in immunocompetent patients 1, 2, 3
  • The American Thoracic Society notes that specificity is excellent with less than 5% false-positive rate in endemic area residents outside outbreak periods 1, 2, 3
  • The Centers for Disease Control and Prevention states that sensitivity drops dramatically to only 18% in organ transplant recipients 4, 5
  • The Centers for Disease Control and Prevention reports that sensitivity is only 45% in HIV/AIDS patients 4, 5

Diagnostic Approach

  • The American Thoracic Society advises against relying on antibody testing alone in immunocompromised patients—combine with antigen testing for optimal diagnostic yield 1
  • The American Thoracic Society recommends that for immunocompetent patients with suspected pulmonary histoplasmosis, order both Histoplasma serology and antigen testing simultaneously 1
  • The Centers for Disease Control and Prevention suggests that for CNS disease, test CSF for both antibody (70-90% sensitivity) and antigen (40-70% sensitivity) 4, 5

Limitations and Considerations

  • The American Thoracic Society notes that antibodies take weeks to develop after initial exposure, making serology less useful for acute diagnosis 1, 2
  • The Centers for Disease Control and Prevention states that in acute pulmonary histoplasmosis, antigen testing becomes positive before antibody detection 4, 5
  • The American Thoracic Society warns that cross-reactions occur with blastomycosis, coccidioidomycosis, paracoccidioidomycosis, and talaromycosis 1, 2, 3
  • The Infectious Diseases Society of America recommends that clinical correlation with exposure history and geographic location is essential for accurate interpretation 6

Diagnóstico de Histoplasmosis

Métodos Diagnósticos Validados

  • La American Thoracic Society establece que los métodos diagnósticos no basados en cultivo más aceptados son la detección de antígeno y anticuerpos, no el examen de capa leucocitaria 7, 8, 9

Detección de Antígeno de Histoplasma

  • La detección de antígeno es el método diagnóstico rápido de elección para histoplasmosis diseminada en pacientes inmunocomprometidos, con sensibilidad combinada de 83.9% para antigenemia y 79.5% para antigenuria 7, 8, 9

Algoritmo Diagnóstico Recomendado

  • Para pacientes inmunocomprometidos con sospecha de histoplasmosis diseminada, se recomienda solicitar antígeno de Histoplasma en orina y suero simultáneamente 7, 8
  • Para pacientes inmunocompetentes con histoplasmosis pulmonar aguda, se recomienda combinar antígeno y serología, lo que aumenta la sensibilidad a 96.3% 7, 9

Mortalidad y Urgencia Diagnóstica

  • La mortalidad en histoplasmosis se estima en 5% en niños y 8% en adultos, y el diagnóstico rápido es esencial para permitir inicio temprano de terapia antifúngica apropiada 7, 8, 9

REFERENCES

6

Testing for Past Exposure to Histoplasmosis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025